Cosmetic cross-reference Noindex: medium evidence

Chromium

CAS 7440-47-3

Chromium (CAS 7440-47-3) is a pharmaceutical compound with 0 bioactivity targets and 235 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral / FAERS
Adverse signals
235
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Chromium
CAS Number
7440-47-3
Molecular Formula
Cr
InChIKey
VYZAMTAEIAYCRO-UHFFFAOYSA-N
Source Match
EPA DSSTox
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE DSSTox identifiers DTXSID3031022

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Chromium is linked to DTXSID3031022 in DSSTox identifiers.

View industrial chemical data →
SOURCE SIDER side-effect resource 13 side-effect rows

Side Effects

SIDER side-effect terms mapped to the drug or same-CAS compound identity.

Side EffectDrug Name MedDRA TypeConcept ID
Coma chromium LLT C0009421
Coma chromium PT C0009421
Convulsion chromium LLT C0036572
Convulsion chromium PT C0036572
Hepatocellular injury chromium LLT C0151763
Hepatocellular injury chromium PT C0151763
Liver injury chromium PT C0160390
Nausea chromium LLT C0027497
Nausea chromium PT C0027497
Ulcer chromium LLT C0041582
Ulcer chromium PT C0041582
Vomiting chromium LLT C0042963
Vomiting chromium PT C0042963
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Chromium used for in pharmaceutical contexts?

Chromium (CAS 7440-47-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Chromium?

Chromium has 235 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal distension, Alanine aminotransferase increased, Alopecia, Amnesia, Anaemia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Chromium also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Chromium with EU status "prohibited".

What clinical phase is Chromium in?

No phase 1-4 clinical development badge is rendered for Chromium because the matched compound identifier rows do not contain a max-phase value.